IDYA
Ideaya Biosciences Inc
38.10$
+1.9%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | – | – | – | 100.0% | – | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 12.3% | 26.1% | – | – | – | 9.2% | – | – | 39.9% | 796.2% | 1,459.2% | – | – | |
| 87.7% | 73.9% | – | – | – | 90.8% | – | – | 60.1% | -696.2% | -1,359.2% | 100.0% | -13.3% | |
| 419.3% | 988.3% | – | – | – | 2,002.6% | – | – | 39.9% | 796.2% | 1,459.2% | 1,227.2% | 159.7% | |
| 97.8% | 180.2% | – | – | – | 156.5% | – | – | 7.9% | 173.3% | 295.4% | 253.6% | 32.9% | |
| 504.8% | 1,142.3% | – | – | – | 2,149.9% | – | – | 7.9% | 173.3% | 295.4% | 1,480.7% | 79.3% | |
| -417.1% | -1,068.5% | – | – | – | -2,059.1% | – | – | 52.2% | -869.5% | -1,654.6% | -1,380.7% | -92.7% | |
| – | 639.0% | – | – | – | – | – | – | – | – | – | – | – | |
| -341.4% | -865.5% | – | – | – | -1,861.6% | – | – | 57.4% | -765.7% | -1,502.1% | -1,269.6% | -74.8% | |
| -12.8% | 143.3% | – | – | – | – | – | – | – | – | – | – | – | |
| -341.4% | -865.5% | – | – | – | -1,861.6% | – | – | 57.4% | -765.7% | -1,502.1% | -1,269.6% | -74.8% | |
| -329.1% | -839.4% | – | – | – | -1,852.4% | – | – | 52.7% | -858.5% | -1,637.2% | -1,368.1% | -90.7% |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.